Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Epigenic Therapeutics CAR-T cell therapy
- Development stage
- Preclinical
- Lead developer
- Epigenic Therapeutics
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies
- Administration
- Intravenous
01
Overview
Epigenic Therapeutics CAR-T cell therapy is an investigational chimeric antigen receptor (CAR) T-cell therapy currently in the drug discovery phase. Developed using a proprietary epigenetic engineering platform, the therapy aims to modulate gene expression through the regulation of the epigenetic genome rather than traditional DNA sequence editing. While the specific molecular targets and therapeutic indications are currently undisclosed, the program is being advanced through a strategic partnership with an unnamed collaborator. The use of epigenetic modulation is intended to potentially improve the safety, durability, or efficacy of the T-cell product by precisely controlling gene expression profiles.
- Other names
- CAR-T program
Beyond the preview
Go deeper on Epigenic Therapeutics CAR-T cell therapy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Epigenic Therapeutics CAR-T cell therapy.